Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foundation Bio (Foundation BioVentures) is a Seattle-based venture studio and biotechnology company focused on the creation of transformative cell and gene therapy companies. Led by Dr. Andrew Scharenberg, the firm utilizes a proprietary "foundry" model to integrate advanced genome editing, synthetic biology, and immunology into scalable therapeutic platforms. Foundation Bio operates as an incubator, designing and developing innovative technologies that are subsequently spun out into independent, well-capitalized biotech entities. The company has been instrumental in the formation of several high-profile organizations, including Umoja Biopharma, GentiBio, and Be Biopharma. Its primary mission is to develop curative treatments for complex diseases by engineering cells with enhanced functional and therapeutic capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foundation BioVentures.